AO
Allen Operations’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.1M | Hold |
217,657
| – | – | 0.15% | 29 |
|
|
2025
Q1 | $1.15M | Hold |
217,657
| – | – | 0.19% | 24 |
|
|
2024
Q4 | $1.47M | Hold |
217,657
| – | – | 0.23% | 25 |
|
|
2024
Q3 | $1.43M | Hold |
217,657
| – | – | 0.24% | 23 |
|
|
2024
Q2 | $1.63M | Hold |
217,657
| – | – | 0.32% | 24 |
|
|
2024
Q1 | $2.17M | Hold |
217,657
| – | – | 0.41% | 23 |
|
|
2023
Q4 | $2.15M | Hold |
217,657
| – | – | 0.43% | 25 |
|
|
2023
Q3 | $1.67M | Hold |
217,657
| – | – | 0.37% | 27 |
|
|
2023
Q2 | $1.63M | Hold |
217,657
| – | – | 0.36% | 26 |
|
|
2023
Q1 | $1.45M | Hold |
217,657
| – | – | 0.37% | 26 |
|
|
2022
Q4 | $1.68M | Hold |
217,657
| – | – | 0.45% | 26 |
|
|
2022
Q3 | $2.32M | Hold |
217,657
| – | – | 0.62% | 22 |
|
|
2022
Q2 | $1.77M | Hold |
217,657
| – | – | 0.45% | 23 |
|
|
2022
Q1 | $1.56M | Hold |
217,657
| – | – | 0.27% | 29 |
|
|
2021
Q4 | $3.73M | Buy |
217,657
+149,553
| +220% | +$2.56M | 0.52% | 22 |
|
|
2021
Q3 | $1.57M | Hold |
68,104
| – | – | 0.24% | 30 |
|
|
2021
Q2 | $2.49M | Buy |
+68,104
| New | +$2.49M | 0.43% | 25 |
|